Clinical Trial Update: Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating Dysport (abobotulinumtoxinA) as an adjunct to bracing for Adolescent Idiopathic Scoliosis and is currently recruiting at …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adolescent Idiopathic Scoliosis

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Johns Hopkins University | Conditions: Adolescent Idiopathic Scoliosis | Phase 4 | Status: RECRUITING